SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-053558
Filing Date
2004-03-30
Accepted
2004-03-30 13:58:47
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1302261
3 OFFICE LEASE WITH THE TRUSTEES UNDER THE WILL AND THE ESTATE OF JAMES CAMPBELL dex1065.txt EX-10.65 121651
4 INDEMNIFICATION AGREEMENT dex1066.txt EX-10.66 25125
5 CODE OF BUSINESS CONDUCT AND ETHICS dex141.txt EX-14.1 17827
6 SUBSIDIARIES OF THE REGISTRANT dex211.txt EX-21.1 624
7 CONSENT OF KPMG LLP dex231.txt EX-23.1 1435
8 SECTION 302 CEO CERTIFICATION dex311.txt EX-31.1 3211
9 SECTION 302 CFO CERTIFICATION dex312.txt EX-31.2 3250
10 SECTION 906 CEO AND CFO CERTIFICATION dex32.txt EX-32 1828
11 GRAPHIC g10604g23c19.jpg GRAPHIC 83358
  Complete submission text file 0001193125-04-053558.txt   1563473
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20945 | Film No.: 04699777
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10